Rocket Lab (RKLB) closed at $66.15 on November 11, 2026, after a strong post-earnings run, with shares up 44% over four days and trading just below recent resistance. The stock is being supported b...
Rocket Lab (RKLB) is trading like a stock re-rating story, not a tired aerospace name waiting for a catalyst. The latest move followed the company’s November 9 third-quarter 2026 update, which said Rocket Lab posted record revenue, $1.2 billion of backlog, positive GAAP operating cash flow, and guided for record revenue and gross margin expansion in Q4 2026. TipRanks cited the post-earnings move as part of a four-day, 44% gain into November 11, 2026, while Yahoo Finance showed RKLB at $67.20 during market hours on November 11 before the stock later closed at $66.15. citeturn0search0
That matters because the market is not just responding to headline growth. It is rewarding proof that the current business is still scaling while investors wait for Neutron. TipRanks said Q3 revenue rose 73% year over year to $267.8 million, backlog jumped 52% to $3.57 billion, and Rocket Lab secured $515 million in new Neutron launch contracts despite the rocket’s inaugural flight slipping to 2027. citeturn0search0
25 on November 11, with Cantor Fitzgerald’s latest rating shown as Overweight and Needham maintaining Buy while lowering its target from 120 to 100. 5, with a low of $58 and high of $150. That spread signals a market still debating how fast the rerating can continue, but not one that is questioning the core investment case outright.
Source link







